Investigation in Progress — No Complaint Filed Yet
BG&G is actively investigating potential securities fraud claims against The Clorox Company. If a complaint is filed, this page will be updated. Investors are encouraged to contact us now to preserve their rights.
Why Is The Clorox Company (CLX) Under Investigation?
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Clorox Company (“Clorox” or “the Company”) (NYSE: CLX). Investors who purchased Clorox securities are encouraged to obtain additional information and assist the investigation.
The investigation concerns whether Clorox has violated federal securities laws.
What Potential Securities Violations Is BG&G Investigating?
On April 30, 2026, Clorox reported its third-quarter fiscal 2026 financial results and updated its full-year outlook. Among other things, the Company disclosed that gross margin decreased 140 basis points to 43.2%, compared to 44.6% in the prior-year period. In addition, Clorox lowered its full-year fiscal 2026 gross margin outlook, stating that gross margin was now expected to decline 250 to 300 basis points, compared to the Company’s prior expectation at the low end of a 50 to 100 basis point decline range. During the Company’s earnings call, Clorox further disclosed that gross margin came in below expectations due to higher-than-expected supply chain costs and delayed cost savings as the Company prioritized ERP stabilization. Following this news, Clorox’s stock price dropped $9.33 per share, or 9.67%, to close at $87.11 on May 1, 2026.
What Should The Clorox Company (CLX) Investors Do?
If you are aware of any facts relating to this investigation or purchased Clorox securities, you can assist this investigation. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 917-590-0911
How Is The Clorox Company (NYSE: CLX) Stock Trading Today?
How Does BG&G Help Investors in Securities Fraud Investigations?
We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
“Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace.”